Lonza

Top-Feature

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Global Gateway Advisors
Photo
Lonza AG
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
Frost & Sullivan
Photo
Mack Brooks Exhibition Ltd – Part of RX
Photo
Arxada AG
F. Hoffmann-La Roche Ltd
Pricewaterhouse Coopers
Jan Ramakers Fine Chemical
Camelot Management Consultants AG
Lonza Capsugel
Photo
Fraser Dove International
Photo
DCAT - Drug, Chemical & Associated Technologies Association
GETEC Group
Microinnova Engineering GmbH
Thomson Reuters
PP Consulting